217 Queen Street West
Suite 401
Toronto, ON M5V 0R2
Canada
https://www.mindsetpharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. James Andre-Charles Lanthier | Chief Exec. Officer | 357.8k | 37.46k | 1975 |
Mr. Arvin Ramos CPA | Chief Financial Officer | 87.69k | N/A | 1979 |
Mr. Joseph Araujo | Chief Scientific Officer, Member of Scientific Advisory Board & Director | 258.72k | N/A | 1977 |
Mr. Jason Atkinson | VP of Corp. Devel. | 112.44k | N/A | 1988 |
Dr. Abdelmalik Slassi Ph.D. | Sr. VP of Innovation & Member of Scientific Advisory Board | 352.29k | N/A | N/A |
Chris Irwin | Corp. Sec. | N/A | N/A | N/A |
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Mindset Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.